Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib

Background: Impaired B-cell receptor (BCR) function has been associated with the progress of several B-cell malignancies. The spleen tyrosine kinase (SYK) represents a potential therapeutic target in a subset of B-cell neoplasias. In precursor B-acute lymphoblastic leukemia (B-ALL), the pathogenic r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Sender, Sina, Sekora, Anett, Villa Perez, Simon, Chabanovska, Oleksandra, Becker, Annegret, Ngezahayo, Anaclet, Junghanss, Christian, Murua Escobar, Hugo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7827334/
https://ncbi.nlm.nih.gov/pubmed/33435587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados